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1. General Information 
a. Materials 
All manipulations were carried out under air. The following chemicals were 
purchased and used as received: Ru(bpy)3Cl2
.
6H2O (Aldrich or TCI), Na2S2O8 
(Aldrich), aromatic compounds (Aldrich or TCI). Ru(bpy)3(ClO4)3
[1]
, substrates 1i
[2]
, 
1j
[2]
, 1o
[3]
, 1s
[4]
, 1t
[5]
, 1x
[2]
, 7
[3]
 and 9
[6]
 were prepared according to previously 
reported procedures. All other reagents and solvents were purchased from commercial 
sources and used without purification. 
b. Analytical Methods 
NMR spectra were recorded on Bruker Avance 400 MHz spectrometers. 
1
H NMR 
chemical shifts were referenced to residual protio solvent peaks or tetramethylsilane 
signal (0 ppm), and 
13
C NMR chemical shifts were referenced to the solvent 
resonance. Data for 
1H NMR are recorded as follows: chemical shift (δ, ppm), 
multiplicity (s = singlet, d = doublet, t = triplet, m = multiplet or unresolved, coupling 
constant (s) in Hz, integration). Data for 
13
C NMR are reported in terms of chemical 
shift (δ, ppm). GC measurements were conducted on a Perkin-Elmer Clarus 400 GC 
with a FID detector. GC-MS measurements were conducted on an Agilent 
Technologies 7890A GC system equipped with a 5975C MS detector. HRMS (ESI, 
APCI and EI) measurements were conducted at the EPFL ISIC Mass Spectrometry 
Service with a Micro Mass QTOF.
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2. Optimization of Reaction Conditions 
 
Table S1: Optimization of reaction conditions
[a]
 
 
[a] Reaction conditions: Toluene (0.25 mmol) in CH3CN/H2O (1 mL) at 25 C. 
Yields were obtained from the crude reaction mixture by GC relative to 
mesitylene internal standard. [b] Without light. 
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3. Preparation of Substrate 
 
Methyl 4-((tert-butoxycarbonyl)amino)-2-methoxybenzoate (11) was prepared 
according to previously reported procedure.
[7]
 White solid (1.22g, 72%).  
1
H NMR 
(400 MHz, CDCl3) δ 7.77 (d, J = 8.6 Hz, 1H, aryl-H), 7.37 (s, 1H, aryl-H), 6.90 (s, 1H, 
NH), 6.74 (dd, J = 8.5, 2.0 Hz, 1H, aryl-H), 3.88 (s, 3H), 3.84 (s, 3H), 1.49 (s, 9H, 
C(CH3)3).  
13
C NMR (101 MHz, CDCl3) δ 166.2, 160.9, 152.4 (aryl-C), 144.0 
(aryl-C), 133.1 (aryl-C), 113.6 (aryl-C), 109.3 (aryl-C), 101.6 (aryl-C), 81.2 
(C(CH3)3), 56.1 (ArOCH3), 51.9 (COOCH3), 28.4 (C(CH3)3).  HRMS-ESI (m/z): 
Calcd for [(C14H19NO5+H)+], 282.1342 ; found: 282.1343. 
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4. Chlorination of Aromatic Compounds 
 
General procedure for chloronation of aromatic compounds: In the air, 
Ru(bpy)3Cl2
.
6H2O (11.2 mg, 3 mol% or 18.7 mg 5 mol%), Na2S2O8 (190 mg, 0.8 
mmol, 1.6 equiv or 238 mg, 2.0 equiv), NaCl (88 mg, 1.5 mmol, 3 equiv), substrate 
(0.5 mmol) and solvent (CH3CN/H2O = 1/1, 2 mL) were added to a 8 mL vial 
equipped with a magnetic stir bar. The reaction was placed in the photoreactor and 
stirred at room temperature for 15~24 h. The resulting solution was extracted with 
ethyl acetate (3 mL x 3), after which the organic solution was combined and dried 
over Na2SO4. Then the solvent was evaporated under vacuum and the residue was 
purified by chromatography on silica gel, eluting with the mixture of ethyl 
acetate/hexane to give the corresponding products. 
 
4-(4-chlorophenyl)butanenitrile (2d). 2d and 2d' were synthesized following the 
general procedure. The residue was purified by chromatography on silica gel, eluting 
with hexane/ethyl acetate (20:1) to give the title compound as colorless oil (42.0 mg, 
49%).  
1
H NMR (400 MHz, CDCl3) δ 7.30 (d, J = 8.5 Hz, 2H, aryl-H), 7.14 (d, J = 
8.3 Hz, 2H, aryl-H), 2.77 (t, J = 7.5 Hz, 1H), 2.34 (t, J = 7.0 Hz, 1H), 1.97 (p, J = 7.2 
Hz, 1H).  
13
C NMR (101 MHz, CDCl3) δ 138.2 (aryl-C), 132.4 (aryl-C), 129.9 
(aryl-C), 128.9 (aryl-C), 119.4 (CN), 33.8, 26.8, 16.4.  HRMS-NSI (m/z): Calcd for 
[(C10H10ClN+H)+], 180.0575; found: 180.0570. 
 
4-(2-chlorophenyl)butanenitrile (2d’). 2d and 2d' were synthesized following the 
general procedure. The residue was purified by chromatography on silica gel, eluting 
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with hexane/ethyl acetate (20:1) to give the title compound as colorless oil (38.0 mg, 
42%).  
1
H NMR (400 MHz, CDCl3) δ 7.36 (dd, J = 6.8, 2.0 Hz, 1H, aryl-H), 7.25 – 
7.16 (m, 3H, aryl-H), 2.90 (t, J = 7.6 Hz, 2H), 2.36 (t, J = 7.1 Hz, 2H), 2.01 (m, 2H).  
13
C NMR (101 MHz, CDCl3) δ 137.6 (aryl-C), 134.1 (aryl-C), 130.7 (aryl-C), 129.9 
(aryl-C), 128.2 (aryl-C), 127.2 (aryl-C), 119.5 (CN), 32.5, 25.4, 16.7.  HRMS-NSI 
(m/z): Calcd for [(C10H10ClN+H)+], 180.0575; found: 180.0569. 
 
3-(2-chlorophenyl)propyl acetate (2e). 2e and 2e' were synthesized following the 
general procedure. The residue was purified by chromatography on silica gel, eluting 
with hexane/ethyl acetate (30:1~10:1) to give the title compound as colorless oil (49.6 
mg, 47%).  
1
H NMR (400 MHz, CDCl3) δ 7.25 (d, J = 7.8 Hz, 2H, aryl-H), 7.11 (d, J 
= 8.0 Hz, 2H, aryl-H), 4.07 (t, J = 6.5 Hz, 2H), 2.66 (t, J = 7.7 Hz, 2H), 2.05 (s, 3H, 
COCH3), 1.97 – 1.88 (m, 2H).  
13
C NMR (101 MHz, CDCl3) δ 171.2 (COOCH3), 
139.8 (aryl-C), 131.9 (aryl-C), 129.9 (aryl-C), 128.7 (aryl-C), 63.7, 31.7, 30.2, 21.1.  
These spectroscopic data correspond to reported data.
[8]
 
 
3-(4-chlorophenyl)propyl acetate (2e’). 2e and 2e' were synthesized following the 
general procedure. The residue was purified by chromatography on silica gel, eluting 
with hexane/ethyl acetate (30:1~10:1) to give the title compound as colorless oil (45.0 
mg, 42%).  
1
H NMR (400 MHz, CDCl3) δ 7.34 (dd, J = 7.7, 1.4 Hz, 1H, aryl-H), 
7.23 – 7.11 (m, 3H, aryl-H), 4.10 (t, J = 6.5 Hz, 2H), 2.81 (t, J = 7.6 Hz, 2H), 2.06 (s, 
3H, COCH3), 2.01 – 1.92 (m, 2H).  
13
C NMR (101 MHz, CDCl3) δ 171.2 (COOCH3), 
138.9 (aryl-C), 134.1 (aryl-C), 130.5 (aryl-C), 129.7 (aryl-C), 127.7 (aryl-C), 126.9 
(aryl-C), 63.9 (COOCH3), 30.2, 28.6, 21.1.  HRMS-NSI (m/z): Calcd for 
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[(C11H13ClO2+Na)+], 235.0496; found: 235.0488.
 
 
1-chloro-4-(3-chloropropyl)benzene (2f). 2f and 2f' were synthesized following the 
general procedure. The residue was purified by chromatography on silica gel, eluting 
with hexane/ethyl acetate (50:1~30:1) to give the title compound as colorless oil 
Colorless oil (47.3 mg, 50%).  
1
H NMR (400 MHz, CDCl3) δ 7.27 (d, J = 8.4 Hz, 2H, 
aryl-H), 7.13 (d, J = 8.4 Hz, 2H, aryl-H), 3.52 (t, J = 6.4 Hz, 2H), 2.76 (t, J = 7.4 Hz, 
2H), 2.10 – 2.02 (m, 2H).  13C NMR (101 MHz, CDCl3) δ 139.2 (aryl-C), 132.0 
(aryl-C), 130.0 (aryl-C), 128.7 (aryl-C), 44.1, 34.0, 32.2.  These spectroscopic data 
correspond to reported data.
[9]
 
 
1-chloro-2-(3-chloropropyl)benzene (2f’). 2f and 2f' were synthesized following the 
general procedure. The residue was purified by chromatography on silica gel, eluting 
with hexane/ethyl acetate (50:1~30:1) to give the title compound as colorless oil (47.3 
mg, 50%). Colorless oil (33.0 mg, 35%).  
1
H NMR (400 MHz, CDCl3) δ 7.35 (dd, J 
= 7.6, 1.7 Hz, 1H, aryl-H), 7.24 – 7.13 (m, 3H, aryl-H), 3.56 (t, J = 6.5 Hz, 2H), 2.91 
(t, J = 7.6 Hz, 2H), 2.15 – 2.07 (m, 2H).  13C NMR (101 MHz, CDCl3) δ 138.5 
(aryl-C), 134.8 (aryl-C), 130.8 (aryl-C), 129.8 (aryl-C), 127.8 (aryl-C), 127.0 (aryl-C), 
44.4, 32.4, 30.9.
[9]
   
 
1-(3-bromopropyl)-4-chlorobenzene (2g). 2g and 2g' were synthesized following 
the general procedure. The residue was purified by chromatography on silica gel, 
eluting with hexane/ethyl acetate (50:1~30:1) to give the title compound as colorless 
oil (45.0 mg, 39%).  
1
H NMR (400 MHz, CDCl3) δ 7.27 (d, J = 8.4 Hz, 2H, aryl-H), 
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7.14 (d, J = 8.4 Hz, 2H, aryl-H), 3.38 (t, J = 6.5 Hz, 1H), 2.76 (t, J = 7.4 Hz, 1H), 2.18 
– 2.10 (m, 2H).  13C NMR (101 MHz, CDCl3) δ 139.1 (aryl-C), 132.1 (aryl-C), 130.0 
(aryl-C), 128.7 (aryl-C), 34.1, 33.4, 32.9.  These spectroscopic data correspond to 
reported data.
[10]
  
 
1-(3-bromopropyl)-2-chlorobenzene (2g’). 2g and 2g' were synthesized following 
the general procedure. The residue was purified by chromatography on silica gel, 
eluting with hexane/ethyl acetate (50:1~30:1) to give the title compound as colorless 
oil (39.1 mg, 33%).  
1
H NMR (400 MHz, CDCl3) δ 7.35 (dd, J = 7.5, 1.7 Hz, 1H, 
aryl-H), 7.26 (dd, J = 7.3, 2.0 Hz, 1H, aryl-H), 7.23 – 7.13 (m, 2H, aryl-H), 3.43 (t, J 
= 6.6 Hz, 2H), 2.90 (t, J = 7.4 Hz, 2H), 2.30 – 2.15 (m, 2H).  13C NMR (101 MHz, 
CDCl3) δ 138.3 (aryl-C), 134.1 (aryl-C), 130.8 (aryl-C), 129.8 (aryl-C), 127.9 (aryl-C), 
127.0 (aryl-C), 33.2, 32.5, 32.2.  These spectroscopic data correspond to reported 
data.
[10]
 
 
2-(4-chlorophenyl)propan-2-ol (2h). 2h and 2h' were synthesized following the 
general procedure. The residue was purified by chromatography on silica gel, eluting 
with hexane/ethyl acetate (20:1~5:1) to give the title compound as colorless oil (48.2 
mg, 57%).  
1
H NMR (400 MHz, CDCl3) δ 7.41 (d, J = 8.6 Hz, 2H, aryl-H), 7.29 (d, J 
= 8.6 Hz, 2H, aryl-H), 1.94 (s, 1H, OH), 1.55 (s, 6H, CH(CH3)3).  
13
C NMR (101 
MHz, CDCl3) δ 147.7 (aryl-C), 132.5 (aryl-C), 128.4 (aryl-C), 126.1 (aryl-C), 72.4 
(CH(CH3)3), 31.9 (CH(CH3)3).  These spectroscopic data correspond to reported 
data.
[11]
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2-(2-chlorophenyl)propan-2-ol (2h’). 2h and 2h' were synthesized following the 
general procedure. The residue was purified by chromatography on silica gel, eluting 
with hexane/ethyl acetate (20:1~5:1) to give the title compound as colorless oil (15.2 
mg, 18%).  
1
H NMR (400 MHz, CDCl3) δ 7.69 (dd, J = 7.8, 1.8 Hz, 1H, aryl-H), 
7.38 (dd, J = 7.8, 1.5 Hz, 1H, aryl-H), 7.28 (td, J = 7.6, 1.5 Hz, 1H, aryl-H), 7.21 (td, 
J = 7.6, 1.8 Hz, 1H, aryl-H), 2.70 (s, 1H, OH), 1.76 (s, 6H, CH(CH3)3).  
13
C NMR 
(101 MHz, CDCl3) δ 144.7 (aryl-C), 131.4 (aryl-C), 131.3 (aryl-C), 128.3 (aryl-C), 
127.0 (aryl-C), 126.9 (aryl-C), 73.1 (CH(CH3)3), 29.4 (CH(CH3)3).  These 
spectroscopic data correspond to reported data.
[12]
 
 
N-(4-chlorophenyl)acetamide (2i). 2i and 2i' were synthesized following the general 
procedure. The residue was purified by chromatography on silica gel, eluting with 
hexane/ethyl acetate (2:1~1:1) to give the title compound as white solid (43.7 mg, 
52%).  
1
H NMR (400 MHz, CDCl3) δ 8.17 (s, 1H, NH), 7.29 (d, J = 8.9 Hz, 2H, 
aryl-H), 7.04 (d, J = 8.9 Hz, 2H, aryl-H), 1.79 (s, 3H, COCH3).  
13
C NMR (101 MHz, 
CDCl3) δ 168.4 (COCH3), 134.7 (aryl-C), 129.1 (aryl-C), 127.8 (aryl-C), 124.7 
(aryl-C), 122.7 (aryl-C), 121.8 (aryl-C), 25.0 (COCH3).  These spectroscopic data 
correspond to reported data.
[13]
 
 
N-(2-chlorophenyl)acetamide (2i’). 2i and 2i' were synthesized following the 
general procedure. The residue was purified by chromatography on silica gel, eluting 
with hexane/ethyl acetate (2:1~1:1) to give the title compound as white solid (25.6 mg, 
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30%).  
1
H NMR (400 MHz, CD3CN) δ 8.36 (d, J = 8.3 Hz, 1H, aryl-H), 7.66 (s, 1H, 
NH), 7.37 (d, J = 7.9 Hz, 1H, aryl-H), 7.28 (t, J = 7.8 Hz, 1H, aryl-H), 7.05 (t, J = 7.5 
Hz, 1H, aryl-H), 2.25 (s, 3H, COCH3).  
13
C NMR (101 MHz, CD3CN) δ 170.2 
(COCH3), 139.5 (aryl-C), 130.1 (aryl-C), 129.1 (aryl-C), 122.1 (aryl-C), 24.8 
(COCH3).  These spectroscopic data correspond to reported data.
[7]
  
 
N-(4-chlorophenyl)-N-methylacetamide (2j). 2j was synthesized following the 
general procedure. The residue was purified by chromatography on silica gel, eluting 
with hexane/ethyl acetate (1:1) to give the title compound as white solid (62.0 mg, 
67%).  
1
H NMR (400 MHz, CDCl3) δ 7.37 (d, J = 8.2 Hz, 1H, aryl-H), 7.12 (d, J = 
8.2 Hz, 1H, aryl-H), 3.22 (s, 3H), 1.85 (s, 3H).  
13
C NMR (101 MHz, CDCl3) δ 170.3 
(COCH3), 143.1 (aryl-C), 133.5 (aryl-C), 130.0 (aryl-C), 128.5 (aryl-C), 37.2, 22.4.  
These spectroscopic data correspond to reported data.
[14]  
 
3-chloro-4-methoxybenzonitrile (2m). 2m was synthesized following the general 
procedure. The residue was purified by chromatography on silica gel, eluting with 
hexane/ethyl acetate (15:1~10:1) to give the title compound as white solid (60.0 mg, 
72%).  
1
H NMR (400 MHz, CDCl3) δ 7.65 (d, J = 2.1 Hz, 1H, aryl-H), 7.55 (dd, J = 
8.6, 2.1 Hz, 1H, aryl-H), 6.98 (d, J 8.6 Hz, 1H, aryl-H), 3.96 (s, 3H, ArOCH3).  
13
C 
NMR (101 MHz, CDCl3) δ 158.6 (aryl-C), 133.6 (aryl-C), 132.5 (aryl-C), 123.6 
(aryl-C), 117.9 (aryl-C), 112.3 (aryl-C), 104.8 (ArCN), 56.5 (ArOCH3).  These 
spectroscopic data correspond to reported data.
[15] 
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1-(3-chloro-4-methoxyphenyl)ethan-1-one (2n). 2n was synthesized following the 
general procedure. The residue was purified by chromatography on silica gel, eluting 
with hexane/ethyl acetate (20:1) to give the title compound as white solid (75.6 mg, 
82%).  
1
H NMR (400 MHz, CDCl3) δ 7.92 (d, J = 2.2 Hz, 1H, aryl-H), 7.80 (dd, J = 
8.6, 2.2 Hz, 1H, aryl-H), 6.91 (d, J = 8.6 Hz, 1H, aryl-H), 3.92 (s, 3H, ArOCH3), 2.50 
(s, 3H, COCH3).  
13
C NMR (101 MHz, CDCl3) δ 195.7 (COCH3), 158.7 (aryl-C), 
130.8 (aryl-C), 130.6 (aryl-C), 128.8 (aryl-C), 122.8 (aryl-C), 111.3 (aryl-C), 56.4 
(ArOCH3), 26.3 (COCH3).  These spectroscopic data correspond to reported data.
[16]
  
 
3-chloro-N,N-diethyl-4-methoxybenzamide (2o). 2o was synthesized following the 
general procedure. The residue was purified by chromatography on silica gel, eluting 
with hexane/ethyl acetate (3:1~2:1) to give the title compound as colorless oil (104.2 
mg, 86%).  
1
H NMR (400 MHz, CDCl3) δ 7.38 (d, J = 2.1 Hz, 1H, aryl-H), 7.23 (dd, 
J = 8.4, 2.1 Hz, 1H, aryl-H), 6.89 (d, J = 8.4 Hz, 1H, aryl-H), 3.87 (s, 3H, ArOCH3), 
3.37 (br, 4H, NCH2CH3), 1.13 (br, 6H, NCH2CH3).  
13
C NMR (101 MHz, CDCl3) δ 
169.7 (CONEt2), 155.7 (aryl-C), 130.3 (aryl-C), 128.7 (aryl-C), 126.3 (aryl-C), 122.4 
(aryl-C), 111.7 (aryl-C), 56.2 (ArOCH3), 43.3 (NCH2CH3), 39.6 (NCH2CH3), 14.1 
(NCH2CH3), 12.9 (NCH2CH3).  HRMS-ESI (m/z): Calcd for [(C12H16ClNO2+H)+], 
242.0948; found: 242.0952. 
 
Methyl 3-chloro-4-methoxybenzoate (2p). 2p was synthesized following the general 
procedure. The residue was purified by chromatography on silica gel, eluting with 
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hexane/ethyl acetate (10:1) to give the title compound as white solid (84.5 mg, 84%).  
1
H NMR (400 MHz, CDCl3) δ 8.05 (d, J = 2.1 Hz, 1H, aryl-H), 7.93 (dd, J = 8.6, 2.1 
Hz, 1H, aryl-H), 6.94 (d, J = 8.6 Hz, 1H, aryl-H), 3.96 (s, 3H, COOCH3), 3.89 (s, 3H, 
ArOCH3).  
13
C NMR (101 MHz, CDCl3) δ 165.8 (COOCH3), 158.6 (aryl-C), 131.6 
(aryl-C), 129.9 (aryl-C), 123.3 (aryl-C), 122.5 (aryl-C), 111.2 (aryl-C), 56.3 
(ArOCH3), 52.2 (COOCH3).  These spectroscopic data correspond to reported 
data.
[17]  
 
2-chloro-1-methoxy-4-nitrobenzene (2q). 2q was synthesized following the general 
procedure. The residue was purified by chromatography on silica gel, eluting with 
hexane/ethyl acetate (20:1~10:1) to give the title compound as white solid (51.0 mg, 
55%).  
1
H NMR (400 MHz, CDCl3) δ 8.05 (d, J = 2.1 Hz, 1H, aryl-H), 7.93 (dd, J = 
8.6, 2.1 Hz, 1H, aryl-H), 6.94 (d, J = 8.6 Hz, 1H, aryl-H), 3.96 (s, 3H), 3.89 (s, 3H).  
13
C NMR (101 MHz, CDCl3) δ 160.2 (aryl-C), 141.3 (aryl-C), 126.0 (aryl-C), 124.1 
(aryl-C), 123.3 (aryl-C), 111.1 (aryl-C), 57.0 (ArOCH3).  These spectroscopic data 
correspond to reported data.
[18] 
 
 
3-chloro-4-methoxyphenyl acetate (2r). 2r was synthesized following the general 
procedure. The residue was purified by chromatography on silica gel, eluting with 
hexane/ethyl acetate (20:1~10:1) to give the title compound as yellow oil (77.1 mg, 
77%).  
1
H NMR (400 MHz, CDCl3) δ 7.14 (d, J = 2.7 Hz, 1H, aryl-H), 6.96 (dd, J = 
8.9, 2.7 Hz, 1H, aryl-H), 6.88 (d, J = 8.9 Hz, 1H, aryl-H), 3.86 (s, 3H, OCOCH3), 2.25 
(s, 3H, ArOCH3).  
13
C NMR (101 MHz, CDCl3) δ 169.5 (OCOCH3), 153.0 (aryl-C), 
143.9 (aryl-C), 123.7 (aryl-C), 122.6 (aryl-C), 120.7 (aryl-C), 112.1 (aryl-C), 56.5 
(ArOCH3), 21.0 (OCOCH3).  HRMS-APCI (m/z): Calcd for [(C9H9ClO3+H)+], 
201.0313; found: 201.0314.
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Methyl 3-chloro-4-methoxybenzenesulfonate (2s). 2s was synthesized following the 
general procedure. The residue was purified by chromatography on silica gel, eluting 
with hexane/ethyl acetate (10:1~5:1) to give the title compound as pale yellow oil 
(50.0 mg, 42%).  
1
H NMR (400 MHz, CDCl3) δ 7.89 (d, J = 2.3 Hz, 1H, aryl-H), 
7.79 (dd, J = 8.7, 2.3 Hz, 1H, aryl-H), 7.04 (d, J = 8.7 Hz, 1H, aryl-H), 3.98 (s, 3H), 
3.98 (s, 3H).  
13
C NMR (101 MHz, CDCl3) δ 159.4 (aryl-C), 130.1 (aryl-C), 128.6 
(aryl-C), 127.4 (aryl-C), 123.7 (aryl-C), 111.9 (aryl-C), 56.7，56.5.  HRMS-NSI (m/z): 
Calcd for [(C8H9ClO4S+Na)+], 258.9802; found: 258.9795. 
 
2,4-dichloro-1-methoxybenzene (2t). 2t was synthesized following the general 
procedure. The residue was purified by chromatography on silica gel, eluting with 
hexane/ethyl acetate (30:1) to give the title compound as pale yellow oil (55.0 mg, 
62%).  
1
H NMR (400 MHz, CDCl3) δ 7.36 (d, J = 2.6 Hz, 1H, aryl-H), 7.19 (dd, J = 
8.8, 2.6 Hz, 1H, aryl-H), 6.84 (d, J = 8.8 Hz, 1H, aryl-H), 3.88 (s, 3H, ArOCH3).  
13
C 
NMR (101 MHz, CDCl3) δ 154.0 (aryl-C), 130.1 (aryl-C), 127.7 (aryl-C), 125.8 
(aryl-C), 123.4 (aryl-C), 112.9 (aryl-C), 56.5 (ArOCH3).  These spectroscopic data 
correspond to reported data.
[19] 
 
 
1-(3-chloro-4-ethoxyphenyl)ethan-1-one (2u). 2u was synthesized following the 
general procedure. The residue was purified by chromatography on silica gel, eluting 
with hexane/ethyl acetate (10:1) to give the title compound as pale yellow solid (78.7 
mg, 79%).  
1
H NMR (400 MHz, CDCl3) δ 7.95 (d, J = 2.2 Hz, 1H, aryl-H), 7.80 (dd, 
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J = 8.6, 2.2 Hz, 1H, aryl-H), 6.90 (d, J = 8.6 Hz, 1H, aryl-H), 4.15 (q, J = 7.0 Hz, 2H, 
ArOCH2CH3), 2.51 (s, 3H, COCH3), 1.47 (t, J = 7.0 Hz, 3H, ArOCH2CH3).  
13
C 
NMR (101 MHz, CDCl3) δ 195.8 (COCH3), 158.3 (aryl-C), 130.7 (aryl-C), 130.6 
(aryl-C), 128.8 (aryl-C), 123.0 (aryl-C), 112.1 (aryl-C), 65.0 (ArOCH2CH3), 26.3 
(COCH3), 14.6 (ArOCH2CH3).  HRMS-ESI (m/z): Calcd for [(C10H11ClO2+H)+], 
199.0526; found: 199.0527.  
 
3-chloro-4-ethoxybenzonitrile (2v). 2j was synthesized following the general 
procedure. The residue was purified by chromatography on silica gel, eluting with 
hexane/ethyl acetate (30:1~10:1) to give the title compound as white solid (71.2 mg, 
78%).  
1
H NMR (400 MHz, CDCl3) δ 7.60 (d, J = 2.1 Hz, 1H, aryl-H), 7.49 (dd, J = 
8.6, 2.1 Hz, 1H, aryl-H), 6.93 (d, J = 8.6 Hz, 1H, aryl-H), 4.14 (q, J = 7.0 Hz, 2H, 
ArOCH2CH3), 1.48 (t, J = 7.0 Hz, 3H, ArOCH2CH3).  
13
C NMR (101 MHz, CDCl3) 
δ 158.1 (aryl-C), 133.6 (aryl-C), 132.4 (aryl-C), 123.7 (aryl-C), 118.0 (aryl-C), 113.0 
(aryl-C), 104.3(CN), 65.2 (ArOCH2CH3), 14.4 (ArOCH2CH3).  HRMS-APCI (m/z): 
Calcd for [(C9H8ClNO+H)+], 182.0367; found: 182.0370.  
 
Methyl 4-acetamido-3-chlorobenzoate (2w). 2w was synthesized following the 
general procedure. The residue was purified by chromatography on silica gel, eluting 
with hexane/ethyl acetate (3:1) to give the title compound as white solid (100.3 mg, 
88%).  
1
H NMR (400 MHz, CDCl3) δ 8.48 (d, J = 8.7 Hz, 1H, aryl-H), 8.02 (d, J = 
1.9 Hz, 1H, aryl-H), 7.90 (dd, J = 8.7, 1.9 Hz, 1H, aryl-H), 7.81 (s, 1H, NH), 3.88 (s, 
3H, COOCH3), 2.25 (s, 3H, NHCOCH3).  
13
C NMR (101 MHz, CDCl3) δ 168.5, 
165.5, 138.6 (aryl-C), 130.3 (aryl-C), 129.2 (aryl-C), 126.0 (aryl-C), 122.0 (aryl-C), 
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120.5 (aryl-C), 52.3 (COOCH3), 24.9 (NHCOCH3).  These spectroscopic data 
correspond to reported data.
[20]
  
 
N-(2-chloro-4-(trifluoromethyl)phenyl)acetamide (2x). 2x was synthesized 
following the general procedure. The residue was purified by chromatography on 
silica gel, eluting with hexane/ethyl acetate (3:1) to give the title compound as white 
solid (105.1 mg, 89%).  
1
H NMR (400 MHz, CDCl3) δ 8.53 (d, J = 8.7 Hz, 1H, 
aryl-H), 7.78 (s, NH), 7.61 (s, 1H, aryl-H), 7.49 (d, J = 8.6 Hz, 1H, aryl-H), 2.26 (s, 
3H, COCH3).  
13
C NMR (101 MHz, CDCl3) δ 168.6 (C=O), 137.8 (aryl-C), 126.5 (q, 
J = 33.5 Hz, aryl-C), 126.2 (q, J = 4.1 Hz, aryl-C), 125.0 (q, J = 3.7 Hz, aryl-C), 123.4 
(q, J = 271.9 Hz, CF3), 122.4 (aryl-C), 121.2 (aryl-C), 25.0 (COCH3).
 19
F NMR (376 
MHz, CDCl3) δ = -62.3.  These spectroscopic data correspond to reported data.
[21] 
 
5-chloro-2-methoxybenzonitrile (2y). 2y was synthesized following the general 
procedure. The residue was purified by chromatography on silica gel, eluting with 
hexane/ethyl acetate (10:1~5:1) to give the title compound as white solid (76.6 mg, 
91%).  
1
H NMR (400 MHz, CDCl3) δ 7.53 – 7.47 (m, 2H, aryl-H), 6.92 (d, J = 8.9 
Hz, 1H, aryl-H), 3.93 (s, 3H, ArOCH3).  
13
C NMR (101 MHz, CDCl3) δ 159.9 
(aryl-C), 134.4 (aryl-C), 132.9 (aryl-C), 125.6 (aryl-C), 115.1 (aryl-C), 112.8 (aryl-C), 
103.0 (ArCN), 56.5 (ArOCH3).  These spectroscopic data correspond to reported 
data.
[22]
  
 
Methyl 5-chloro-2-methoxybenzoate (2z). 2z was synthesized following the general 
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procedure. The residue was purified by chromatography on silica gel, eluting with 
hexane/ethyl acetate (10:1~7:1) to give the title compound as pale yellow oil (72.9 mg, 
73%).  
1
H NMR (400 MHz, CDCl3) δ 7.74 (d, J = 2.8 Hz, 1H, aryl-H), 7.39 (dd, J = 
8.9, 2.8 Hz, 1H, aryl-H), 6.90 (d, J = 8.9 Hz, 1H, aryl-H), 3.87 (s, 3H, COOCH3), 3.87 
(s, 3H, ArOCH3).  
13
C NMR (101 MHz, CDCl3) δ 165.4 (COOCH3), 157.8 (aryl-C), 
133.1 (aryl-C), 131.3 (aryl-C), 125.2 (aryl-C), 121.3 (aryl-C), 113.5 (aryl-C), 56.3 
(ArOCH3), 52.2 (COOCH3).  These spectroscopic data correspond to reported data.
 
[23] 
 
2-bromo-4-chloro-1-methoxybenzene (2aa). 2aa was synthesized following the 
general procedure. The residue was purified by chromatography on silica gel, eluting 
with hexane/ethyl acetate (20:1) to give the title compound as pale yellow oil (86.0 
mg, 78%).  
1
H NMR (400 MHz, CDCl3) δ 7.52 (d, J = 2.6 Hz, 1H, aryl-H), 7.23 (dd, 
J = 8.8, 2.5 Hz, 1H, aryl-H), 6.80 (d, J = 8.8 Hz, 1H, aryl-H), 3.87 (s, 3H, ArOCH3).  
13
C NMR (101 MHz, CDCl3) δ 154.9 (aryl-C), 132.9 (aryl-C), 128.4 (aryl-C), 126.1 
(aryl-C), 112.7 (aryl-C), 112.2 (aryl-C), 56.6 (ArOCH3).  These spectroscopic data 
correspond to reported data.
[24]
  
 
1-chloronaphthalene (2ab). 2ab was synthesized following the general procedure. 
The residue was purified by chromatography on silica gel, eluting with hexane/ethyl 
acetate (30:1) to give the title compound as colorless oil (55.0 mg, 68%).  
1
H NMR 
(400 MHz, CDCl3) δ 8.30 (d, J = 8.4 Hz, 1H, aryl-H), 7.87 (d, J = 8.1 Hz, 1H, aryl-H), 
7.78 (d, J = 8.2 Hz, 1H, aryl-H), 7.65 – 7.53 (m, 3H, aryl-H), 7.40 (t, J = 7.8 Hz, 1H, 
aryl-H).  
13
C NMR (101 MHz, CDCl3) δ 134.7 (aryl-C), 132.0 (aryl-C), 130.9 
(aryl-C), 128.3 (aryl-C), 127.3 (aryl-C), 127.2 (aryl-C), 126.8 (aryl-C), 126.3 (aryl-C), 
     
S18 
 
125.8 (aryl-C), 124.5 (aryl-C).  These spectroscopic data correspond to reported 
data.
[25]
 
 
Methyl 2-chloro-5-methoxybenzoate (2ac). 2ac and 2ac' was synthesized following 
the general procedure. The residue was purified by chromatography on silica gel, 
eluting with hexane/ethyl acetate (20:1~15:1) to give the title compound as colorless 
oil (57.3 mg, 57%).  
1
H NMR (400 MHz, CDCl3) δ 7.36 – 7.32 (m, 2H, aryl-H), 6.97 
(dd, J = 8.9, 3.1 Hz, 1H, aryl-H), 3.94 (s, 3H), 3.83 (s, 3H).  
13
C NMR (101 MHz, 
CDCl3) δ 166.1 (COOCH3), 158.0 (aryl-C), 131.9 (aryl-C), 130.7 (aryl-C), 125.0 
(aryl-C), 119.0 (aryl-C), 116.1 (aryl-C), 55.8, 52.6.  These spectroscopic data 
correspond to reported data.
[26]
  
 
Methyl 4-chloro-3-methoxybenzoate (2ac’). 2ac and 2ac' was synthesized following 
the general procedure. The residue was purified by chromatography on silica gel, 
eluting with hexane/ethyl acetate (20:1~15:1) to give the title compound as colorless 
oil (19.7 mg, 20%).  
1
H NMR (400 MHz, CDCl3) δ 7.33 (dd, J = 7.8, 1.6 Hz, 1H, 
aryl-H), 7.26 (t, J = 7.9 Hz, 1H, aryl-H), 7.05 (dd, J = 8.1, 1.6 Hz, 1H, aryl-H), 3.92 (s, 
3H), 3.91 (s, 3H).  
13
C NMR (101 MHz, CDCl3) δ 166.6 (COOCH3), 155.8 (aryl-C), 
132.3 (aryl-C), 127.2 (aryl-C), 122.5 (aryl-C), 122.1 (aryl-C), 114.7 (aryl-C), 56.7, 
52.6.
 
 These spectroscopic data correspond to reported data.
[27]
  
 
1-(2-chloro-5-methoxyphenyl)ethan-1-one (2ad). 2ad and 2ad' was synthesized 
following the general procedure. The residue was purified by chromatography on 
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silica gel, eluting with hexane/ethyl acetate (30:1) to give the title compound as 
colorless oil (38.4 mg, 42%).  
1
H NMR (400 MHz, CDCl3) δ 7.28 (d, J = 8.8 Hz, 1H, 
aryl-H), 7.04 (d, J = 3.1 Hz, 1H, aryl-H), 6.91 (dd, J = 8.8, 3.1 Hz, 1H, aryl-H), 3.79 
(s, 3H, ArOCH3), 2.63 (s, 3H, COCH3).  
13
C NMR (101 MHz, CDCl3) δ 200.4 
(COCH3), 158.4 (aryl-C), 139.8 (aryl-C), 131.6 (aryl-C), 122.7 (aryl-C), 118.3 
(aryl-C), 114.2 (aryl-C), 55.8 (ArOCH3), 30.8 (COCH3).
 
 HRMS-NSI (m/z): Calcd 
for [(C9H9ClO2+H)+], 185.0364; found: 185.0358. 
 
1-(2-chloro-3-methoxyphenyl)ethan-1-one (2ad’). 2ad and 2ad' was synthesized 
following the general procedure. The residue was purified by chromatography on 
silica gel, eluting with hexane/ethyl acetate (30:1) to give the title compound as 
colorless oil (25.0 mg, 27%).  
1
H NMR (400 MHz, CDCl3) δ 7.27 (t, J = 7.9 Hz, 1H, 
aryl-H), 7.04 (dd, J = 7.8, 1.4 Hz, aryl-H), 7.01 (dd, J = 8.2, 1.4 Hz, 1H, aryl-H), 3.92 
(s, 3H, ArOCH3), 2.62 (s, 3H, COCH3).  
13
C NMR (101 MHz, CDCl3) δ 201.2 
(COCH3), 155.5 (aryl-C), 141.5 (aryl-C), 127.8 (aryl-C), 120.3 (aryl-C), 119.5 
(aryl-C), 113.9 (aryl-C), 56.6 (ArOCH3), 31.0 (COCH3).
 
 HRMS-NSI (m/z): Calcd 
for [(C9H9ClO2+H)+], 185.0364; found: 185.0358. 
 
1-bromo-4-methoxybenzene (2af). 2af was synthesized following the general 
procedure. The residue was purified by chromatography on silica gel, eluting with 
hexane/ethyl acetate (10:1) to give the title compound as yellow oil (73.7 mg, 79%).  
1
H NMR (400 MHz, CDCl3) δ 7.38 (d, J = 8.9 Hz, 1H, aryl-H), 6.78 (d, J = 8.9 Hz, 
1H, aryl-H), 3.78 (s, 2H, ArOCH3).  
13
C NMR (101 MHz, CDCl3) δ 158.8 (aryl-C), 
132.3 (aryl-C), 115.8 (aryl-C), 112.9 (aryl-C), 55.5 (ArOCH3).  These spectroscopic 
data correspond to reported data.
[28]
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N-(4-bromophenyl)acetamide (2ag). 2ag was synthesized following the general 
procedure. The residue was purified by chromatography on silica gel, eluting with 
hexane/ethyl acetate (1:1) to give the title compound white solid (103.1 mg, 96%).  
1
H NMR (400 MHz, CDCl3) δ 7.67 (bs, 1H, NH), 7.39 (s, 4H, aryl-H), 2.15 (s, 3H, 
COCH3).  
13
C NMR (101 MHz, CDCl3) δ 168.9 (COCH3), 137.1 (aryl-C), 132.0 
(aryl-C), 121.7 (aryl-C), 117.0 (aryl-C), 24.6 (COCH3).  These spectroscopic data 
correspond to reported data.
[13]
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5. Synthesis of Clofibrate and Some 
Pharmaceutical Intermediates 
 
5-chloro-2-methoxy-N-phenethylbenzamide (8). 8 was synthesized following the 
general procedure of chlorination. The residue was purified by chromatography on 
silica gel, eluting with hexane/ethyl acetate (5:1~3:1) to give the title compound as 
colorless oil (115.6 mg, 80%).  
1
H NMR (400 MHz, CDCl3) δ 8.16 (d, J = 2.8 Hz, 
1H, aryl-H), 7.85 (s, 1H, aryl-H), 7.37 – 7.22 (m, 6H, aryl-H), 6.82 (d, J = 8.8 Hz, 1H, 
aryl-H), 3.80 – 3.69 (m, 5H, OCH3 and NHCH2), 2.92 (t, J = 6.8 Hz, 2H, PhCH2).  
13
C NMR (101 MHz, CDCl3) δ 163.8 (CONH), 155.9 (aryl-C), 139.1 (aryl-C), 132.1 
(aryl-C), 131.7 (aryl-C), 128.8 (aryl-C), 128.5 (aryl-C), 126.4 (aryl-C), 126.4 (aryl-C), 
122.9 (aryl-C), 112.8 (aryl-C), 56.0, 40.8, 35.4. These spectroscopic data correspond 
to reported data.
[29]
 
 
Clofibrate (10a). 10a and 10a' was synthesized following the general procedure of 
chlorination. The residue was purified by chromatography on silica gel, eluting with 
hexane/ethyl acetate (10:1) to give the mixture of 10a and 10a'. These two compound 
were further separated by preparative HPLC (CHIRALPAK IC column, 
hexane/iPrOH = 99.2:0.8) to give the title compound as colorless oil (69.6 mg, 57%).  
1
H NMR (400 MHz, CDCl3) δ 7.18 (d, J = 8.9 Hz, 2H, aryl-H), 6.78 (d, J = 8.9 Hz, 
2H, aryl-H), 4.22 (q, J = 7.1 Hz, 2H, OCH2CH3), 1.57 (s, 6H, C(CH3)2), 1.24 (t, J = 
7.1 Hz, 3H, OCH2CH3).  
13
C NMR (101 MHz, CDCl3) δ 174.1 (C=O), 154.2 
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(aryl-C), 129.2 (aryl-C), 127.3 (aryl-C), 120.7 (aryl-C), 79.6, 61.6, 25.4, 14.2.  These 
spectroscopic data correspond to reported data.
[30]
   
Ethyl 2-(2,4-dichlorophenoxy)-2-methylpropanoate (10a’). 10a and 10a' was 
synthesized following the general procedure of chlorination. The residue was purified 
by chromatography on silica gel, eluting with hexane/ethyl acetate (10:1) to give the 
mixture of 10a and 10a'. These two compound were further separated by preparative 
HPLC (CHIRALPAK IC column, hexane/iPrOH = 99.2:0.8) to give the title 
compound as colorless oil (39.0 mg, 28%).  
1
H NMR (400 MHz, CDCl3) 7.37 (d, J = 
2.6 Hz, 1H, aryl-H), 7.09 (dd, J = 8.8, 2.6 Hz, 1H, aryl-H), 6.85 (d, J = 8.8 Hz, 1H, 
aryl-H), 4.23 (q, J = 7.1 Hz, 2H, OCH2CH3), 1.60 (s, 6H, C(CH3)2), 1.27 (t, J = 7.1 Hz, 
3H, OCH2CH3).  
13
C NMR (101 MHz, CDCl3) δ 173.8 (C=O), 150.5 (aryl-C), 130.2 
(aryl-C), 127.9 (aryl-C), 127.7 (aryl-C), 127.3 (aryl-C), 120.9 (aryl-C), 81.4, 61.8, 
25.2, 14.2.  These spectroscopic data correspond to reported data.
[30]
   
 
Methyl 4-((tert-butoxycarbonyl)amino)-5-chloro-2-methoxybenzoate (12a). 12a 
and 12a' was synthesized following the general procedure of chlorination. The residue 
was purified by chromatography on silica gel, eluting with hexane/ethyl acetate 
(15:1~10:1) to give the title compound as colorless oil (91.3 mg, 58%).  
1
H NMR 
(400 MHz, CDCl3) δ 8.02 (s, 1H, aryl-H), 7.84 (s, 1H, aryl-H), 7.17 (s, 1H, NH), 3.93 
(s, 3H), 3.85 (s, 3H), 1.53 (s, 9H, C(CH3)3).  
13
C NMR (101 MHz, CDCl3) δ 164.9, 
159.4, 151.8 (aryl-C), 139.8 (aryl-C), 132.1 (aryl-C), 113.7 (aryl-C), 111.9 (aryl-C), 
102.4 (aryl-C), 81.8 (C(CH3)3), 56.3 (ArOCH3), 51.9 (COOCH3), 28.2 (C(CH3)3).  
HRMS-ESI (m/z): Calcd for [(C14H18ClNO5+H)+], 316.0952; found: 316.0956. 
Methyl 4-((tert-butoxycarbonyl)amino)-3-chloro-2-methoxybenzoate (12a’). 12a 
and 12a' was synthesized following the general procedure of chlorination. The residue 
was purified by chromatography on silica gel, eluting with hexane/ethyl acetate 
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(15:1~10:1) to give the title compound as colorless oil (18.2 mg, 12%).  
1
H NMR 
(400 MHz, CDCl3) δ 8.06 (d, J = 8.9 Hz, 1H, aryl-H), 7.78 (d, J = 9.0 Hz, 1H, aryl-H), 
7.23 (s, 1H, NH), 3.91 (s, 3H), 3.90 (s, 3H), 1.54 (s, 9H, C(CH3)3).  
13
C NMR (101 
MHz, CDCl3) δ 165.2, 156.7, 151.8 (aryl-C), 140.2 (aryl-C), 130.5 (aryl-C), 119.2 
(aryl-C), 117.0 (aryl-C), 113.7 (aryl-C), 81.8 (C(CH3)3), 61.9 (ArOCH3), 52.1 
(COOCH3), 28.2 (C(CH3)3).  HRMS-ESI (m/z): Calcd for [(C14H18ClNO5+H)+], 
316.0952; found: 316.0957. 
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6. Mechanism study 
 
Scheme S1. Two probably pathways of oxidative chlorination of aromatic compounds 
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A： 
 
B： 
 
Figure S1. (A) Time-dependent UV-vis spectra of Ru(bpy)3
3+
 (1x 10
-3
 M) in CH3CN/H2O (1:1); 
(B) The variation of absorbance at 680 nm on UV-vis spectra. 
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A： 
 
B： 
 
Figure S2. Time-dependent UV-vis spectra of Ru(bpy)3
3+
 (1x 10
-3
 M) with added toluene (2x 
10
-2
 M) in CH3CN/H2O (1:1) ; (B) The variation of absorbance at 680 nm on UV-vis spectra. 
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A： 
 
B： 
 
Figure S3. Time-dependent UV-vis spectra of Ru(bpy)3
3+ 
(1x 10
-3
 M) with added NaCl (6 x 10
-2
 
M) in CH3CN/H2O (1:1); (B) The variation of absorbance at 680 nm on UV-vis spectra. 
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8. NMR Spectra 
 
1
H NMR (400 MHz, CDCl3) of 2d 
 
13
C NMR (101 MHz, CDCl3) of 2d 
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1
H NMR (400 MHz, CDCl3) of 2d’ 
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C NMR (101 MHz, CDCl3) of 2d’ 
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1
H NMR (400 MHz, CDCl3) of 2e 
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C NMR (101 MHz, CDCl3) of 2e 
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1
H NMR (400 MHz, CDCl3) of 2e’ 
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